date,title,source
Oct-18-18,Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings,GlobeNewswire
Oct-22-18,Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346,GlobeNewswire
Oct-25-18,Allena Pharmaceuticals to Present Data Characterizing Significant Unmet Need in Enteric Hyperoxaluria at ASN Kidney Week 2018,GlobeNewswire
Nov-06-18,Allena Pharmaceuticals to Present at Upcoming Investor Conferences in November,GlobeNewswire
